These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 280716

  • 1. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions.
    Watanabe K, Williams GM.
    J Natl Cancer Inst; 1978 Nov; 61(5):1311-4. PubMed ID: 280716
    [Abstract] [Full Text] [Related]

  • 2. Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure.
    Hirota N, Williams GM.
    J Natl Cancer Inst; 1979 Nov; 63(5):1257-65. PubMed ID: 291752
    [Abstract] [Full Text] [Related]

  • 3. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
    Katayama S, Ohmori T, Maeura Y, Croci T, Williams GM.
    J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
    [Abstract] [Full Text] [Related]

  • 4. Ultrastructural abnormalities in carcinogen-induced hepatocellular altered foci identified by resistance to iron accumulation.
    Hirota N, Williams GM.
    Cancer Res; 1982 Jun; 42(6):2298-309. PubMed ID: 7074612
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action.
    Furuya K, Maeura Y, Williams GM.
    Toxicol Pathol; 1984 Jun; 12(2):136-42. PubMed ID: 11478314
    [Abstract] [Full Text] [Related]

  • 9. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC, Popp JA.
    Cancer Res; 1989 Jun 15; 49(12):3246-51. PubMed ID: 2566380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhanced survival and absence of progressive growth of transplanted rat liver altered eosinophilic foci and neoplastic nodules in phenobarbital-treated rats.
    Mori H, Furuya K, Williams GM.
    J Natl Cancer Inst; 1983 Oct 15; 71(4):849-54. PubMed ID: 6194334
    [Abstract] [Full Text] [Related]

  • 17. Effects of a high-sucrose diet on the development of enzyme-altered foci in chemical hepatocarcinogenesis in rats.
    Hei TK, Sudilovsky O.
    Cancer Res; 1985 Jun 15; 45(6):2700-5. PubMed ID: 2859110
    [Abstract] [Full Text] [Related]

  • 18. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W.
    Cancer Res; 1990 Aug 15; 50(16):5127-35. PubMed ID: 2379175
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
    Kraupp-Grasl B, Huber W, Taper H, Schulte-Hermann R.
    Cancer Res; 1991 Jan 15; 51(2):666-71. PubMed ID: 1985784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.